Samjin Pharmaceuticals Co., Ltd. (KRX:005500)
South Korea flag South Korea · Delayed Price · Currency is KRW
19,610
+10 (0.05%)
Feb 20, 2026, 3:30 PM KST

Samjin Pharmaceuticals Ratios and Metrics

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2022FY 2021FY 2012FY 2011FY 2010
Period Ending
Feb '26 Dec '22 Dec '21 Dec '12 Dec '11 Dec '10
240,375344,067327,511140,529104,902150,669
Market Cap Growth
13.95%5.05%133.05%33.96%-30.38%-5.60%
Enterprise Value
-389,035372,478160,616157,311189,264
Last Close Price
19610.0022749.6522613.917248.645257.097333.72
PE Ratio
11.3515.7211.5313.2114.8514.38
PS Ratio
0.881.261.310.760.520.75
PB Ratio
0.871.251.401.250.881.26
P/TBV Ratio
0.911.301.461.270.891.28
P/FCF Ratio
---6.6079.5811.66
P/OCF Ratio
13.9019.9013.674.148.288.95
EV/Sales Ratio
-1.421.490.870.780.94
EV/EBITDA Ratio
-11.799.037.515.797.58
EV/EBIT Ratio
-16.7810.989.286.588.57
EV/FCF Ratio
---7.55119.3314.65
Debt / Equity Ratio
0.320.320.230.380.350.34
Debt / EBITDA Ratio
2.652.651.322.011.531.64
Debt / FCF Ratio
---2.0231.443.17
Net Debt / Equity Ratio
0.300.300.180.290.300.28
Net Debt / EBITDA Ratio
2.512.511.041.551.341.36
Net Debt / FCF Ratio
-4.59-4.59-0.881.5627.552.63
Asset Turnover
0.740.74-0.901.011.06
Inventory Turnover
2.262.26-3.093.263.32
Quick Ratio
0.790.791.401.511.742.12
Current Ratio
1.641.642.831.892.092.60
Return on Equity (ROE)
8.59%8.59%-9.15%5.90%9.14%
Return on Assets (ROA)
3.92%3.92%-5.25%7.48%7.29%
Return on Invested Capital (ROIC)
6.33%6.33%13.05%8.10%4.99%9.50%
Return on Capital Employed (ROCE)
7.10%7.10%12.00%13.00%17.30%16.10%
Earnings Yield
9.11%6.36%8.67%7.57%6.73%6.95%
FCF Yield
-7.51%-5.25%-14.83%15.14%1.26%8.58%
Dividend Yield
4.08%3.52%3.54%--0.68%
Payout Ratio
44.95%44.95%34.65%26.91%9.07%3.56%
Buyback Yield / Dilution
2.00%-3.00%5.52%0.07%1.42%0.02%
Total Shareholder Return
6.12%0.52%9.06%0.07%1.42%0.70%
Updated Nov 14, 2013. Source: S&P Global Market Intelligence. Standard template. Financial Sources.